Progressing from Metformin to Sulfonylureas or Meglitinides

Academic Article

Abstract

  • The article provides an overview of sulfonylureas and meglitinides as second-line agents for treating type 2 diabetes mellitus (T2DM). Implications for occupational health clinicians who work with these individuals when they take either of these medications to achieve target glycemic indices are emphasized.
  • Published In

    Digital Object Identifier (doi)

    Author List

  • Grant JS; Graven LJ
  • Start Page

  • 433
  • End Page

  • 439
  • Volume

  • 64
  • Issue

  • 9